Source link : https://newshealth.biz/health-news/oral-drug-wins-fda-approval-for-chronic-hives/
(MedPage Today) — The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday. Indicated for adults with stubborn symptoms despite the use of… Source link : https://www.medpagetoday.com/allergyimmunology/allergy/117745 Author : Publish date : 2025-10-01 20:32:00 Copyright for syndicated content belongs to the linked Source.
The post Oral Drug Wins FDA Approval for Chronic Hives first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-01 20:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8